Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.

Pierre-Alexandre SquaraVinh-Phuc LuuDavid PérolBruno CoudertValérie MachuronCamille BachotLaurence SamelsonVirginie FlorentinJean-Marc PinguetBéchir Ben Hadj Yahia

Published in: PloS one (2022)

PRM Platform enabled building a national database generating on demand Real-World Evidence based on EPR. This enabled the first performance-based risk-sharing arrangements based on PRM data, between the CEPS and Roche, for atezolizumab cancer immunotherapy in metastatic non-small cell lung cancer indication.

Keyphrases

electronic health record
quality improvement
high throughput
big data
squamous cell carcinoma
papillary thyroid
small cell lung cancer
adverse drug
machine learning
health information
emergency department
squamous cell
artificial intelligence
lymph node metastasis
childhood cancer
single cell